Injectable Vaccine Articles & Analysis
12 news found
With microneedles drilling down into the stratum corneum, it’s less invasive and more painless than ever before for injecting vaccines, hormones and other medications. Protheragen-ING can support customers in all phases of microneedle development. ...
An article presenting analyses of Continuous Glucose Monitoring (CGM) data from the randomised, placebo-controlled Phase 2b trial DIAGNODE-2 that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd®, has been published in the peer-reviewed scientific journal The Journal of Clinical Endocrinology & Metabolism (JCEM). ...
Updated 12-month results from the open-label investigator-initated Phase II clinical trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd® in individuals diagnosed with Latent Autoimmune Diabetes in Adults (LADA) were presented today at the European Association for the Study of Diabetes (EASD) conference in ...
Unlike conventional injectable COVID-19 vaccines, a sublingual COVID-19 vaccine can induce mucosal immunity, thereby effectively preventing viral infections at the mucosal frontier and reducing viral release. In addition, conventional injectable COVID-19 vaccines require storage and distribution in a ...
An article presenting the 5-month interim results from the open-label trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd®, has been published in the peer-reviewed scientific journal Frontiers in Endocrinology. ...
ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming the fill and finish and delivery of injectable vaccines and medicines, announced today that it had completed a $111 million private round of investment. ...
Oravax combines Oramed’s POD™ oral delivery technology with Premas’ proprietary virus like particle (VLP) triple antigen vaccine. The VLP vaccine targets three structural proteins potentially creating a more robust candidate for protection across emerging mutations of the coronavirus. The oral delivery should offer a more user-friendly option ...
“The data suggest a single, adjuvant-free, needle-free intranasal dose of MV-014-212 may provide broad immunity to protect against infection by SARS-CoV-2 and its variants.” Injected vaccines are likely to curtail but not contain transmission, whereas a live attenuated intranasal vaccine has the greatest potential to block ...
In contrast, injected vaccines typically induce circulating but not mucosal antibodies. While circulating antibodies are important for preventing serious lung disease, mucosal antibodies are important for blocking infection and transmission of respiratory viruses. “Compared to injected vaccines, intranasal ...
The translated transcript of the video is as follows: “Vaccination will finally begin in Japan next week, but the development of new vaccination methods that are quick and easy to use are under development. ...
The currently licensed injectable vaccine requires three immunizations in addition to antimicrobial therapy as a medical countermeasure following potential anthrax exposure. ...
The main objectives were to evaluate the safety and the immunogenicity after 3 subcutaneous injections with the CV-MG01 vaccine Population of subjects: The therapeutic vaccine (or placebo) was tested on 24 patients with Myasthenia Gravis, a chronic autoimmune neuromuscular disorder (mean age: 42 years, 24 – 64 years; 18 females, 6 males) ...